Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 7/2017

01-07-2017 | Letter to the Editor

Presidents’ Day reflections. Why Donald Trump could not be a rheumatologist

Authors: Richard S. Panush, Eric L. Matteson

Published in: Clinical Rheumatology | Issue 7/2017

Login to get access

Excerpt

Donald Trump could never be a rheumatologist. Following are the top 10 reasons why.
(1)
It does not pay enough.
 
(2)
We aspire to lofty ethical imperatives.
 
(3)
We seek, and are able to recognize, truth.
 
(4)
We believe in science—not “junk” science- and evidence-based practice.
 
(5)
We aim to help people.
 
(6)
We care about others, particularly the less fortunate.
 
(7)
We embrace altruism and put our patients’ needs before our own.
 
(8)
We try to think, reason, and express ourselves in more than 144 characters.
 
(9)
We strive to be humanistic, and
 
(10)
We fundamentally endeavor to respect others.
 
…
Literature
1.
Panush RS (1996) Upon finding a Nazi anatomy atlas: the lessons of Nazi medicine. The Pharos 59:18–22PubMed
2.
Matteson E, Panush RS (2007) Eponyms should be abandoned. Rheumatology News 6:12
3.
Panush RS, Wallace DJ, Dorff EN, Engleman EP (2007) Retraction of the suggestion to use the term “Reiter’s syndrome” 64 years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 56: 693–694
4.
Woywodt A, Haubitz M, Haller H, Matteson EL (2006) Wegener’s granulomatosis. Lancet 367(9519):1362–1366CrossRefPubMed
5.
Panush RS (2011) Rheum with a view. Why rheumatology and the care of patients with rheumatic disease are important, interesting, and fun. Rheumatologist 5(6):65–68, 70–72
6.
7.
8.
Caplan AL (1992) When medicine went mad: bioethics and the Holocaust (contemporary issues in biomedicine, ethics, and society) softcover reprint of the original 1st ed. 1992 edition. Humana Press, TotowaCrossRef
9.
Berwick DM (2012) To Isaiah. JAMA 307:2595–2599
10.
Quoted in, Ludmerer KM (1999) Time to heal. American medical education from the turn of the century to the era of managed care. New York, Oxford
11.
Metadata
Title
Presidents’ Day reflections. Why Donald Trump could not be a rheumatologist
Authors
Richard S. Panush
Eric L. Matteson
Publication date
01-07-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3620-y

Other articles of this Issue 7/2017

Clinical Rheumatology 7/2017 Go to the issue

Original Article

Association of tumor necrosis factor–α (G-308A) genetic variant with matrix metalloproteinase–9 activity and joint destruction in early rheumatoid arthritis

Brief Report

NLRP12 autoinflammatory disease: a Chinese case series and literature review

Erratum

Erratum to: Predictors of poor sleep quality in patients with systemic lupus erythematosus

Original Article

The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients

Original Article

The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials

Original Article

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits